TSX: ACB
EDMONTON, Jan. 4, 2018 /CNW/ - Aurora Cannabis Inc.
("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced that
today it purchased 91,800 common shares of CanniMed Therapeutics
Inc. ("CanniMed").
The purchases were made in connection with Aurora's previously
announced offer to purchase all of the common shares of CanniMed
(the "Offer"). Aurora announced its intention to
purchase common shares of CanniMed (the "CanniMed Shares")
in its Offer to Purchase and Takeover Bid Circular dated
November 24, 2017, which is filed on
SEDAR under CanniMed's SEDAR profile. CanniMed implemented a
shareholder rights plan on November 28,
2017, which prevented Aurora from commencing purchases in a
timely fashion. The Ontario Securities Commission and the
Saskatchewan Financial and Consumer Affairs Authority, in joint
decisions dated December 22, 2017 and
issued on December 27, 2017, cease
traded the CanniMed rights plan.
The purchases were made by Aurora in the normal course through
the facilities of the TSX.
Name of the Purchaser
Aurora Cannabis Inc.
Number of CanniMed shares purchased on January 4, 2018
91,800
Highest price paid for the CanniMed shares on January 4, 2018
$23.99
Aggregate Number of CanniMed Shares Purchased through a
published market since the Commencement of the
Offer
657,800
Average price paid for the CanniMed shares purchased through
a published market since the Commencement of the
Offer
$22.9817
Total Number of CanniMed Shares held by Aurora after the
Purchase
657,800
How to Tender
Aurora encourages CanniMed shareholders to read the full details
of the Offer set forth in the takeover bid circular and
accompanying offer documents, (collectively, the "Offer
Documents"), which contain detailed instructions on how
CanniMed shareholders can tender their CanniMed common shares to
the Offer. For assistance in depositing CanniMed common shares to
the Offer, CanniMed shareholders should contact the depositary and
the Information Agent for the Offer, Laurel Hill Advisory Group at
Phone: 1-877-452-7184 (North American Toll Free Phone) and
1-416-304-0211 (Outside North America); Facsimile: 416-646-2415;
and E-mail: assistance@laurelhill.com.
About the Offer
On November 24, 2017, Aurora
formally commenced its Offer to purchase all of the issued and
outstanding common shares of CanniMed for consideration consisting
of common shares of Aurora. The Offer Document, including the
takeover bid circular and related documents are available on
SEDAR.
The Offer Documents are also available on Aurora's website at
www.auroramj.com and shareholders are invited to visit
cannimed.auroramj.com for further information.
Stock Options Issued
The Company granted 300,000 stock options to an officer of the
Company exercisable at $9.60 per
common share. The options shall vest quarterly over a period of 36
months and expire five years from the date of grant.
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises
Inc., is a licensed producer of medical cannabis pursuant to Health
Canada's Access to Cannabis for Medical Purposes Regulations
("ACMPR"). The Company operates a 55,200 square foot,
state-of-the-art production facility in Mountain View County,
Alberta, known as "Aurora
Mountain", a second 40,000 square foot high-technology production
facility known as "Aurora Vie" in Pointe-Claire, Quebec on Montreal's West Island, and is currently
constructing an 800,000 square foot production facility, known as
"Aurora Sky", at the Edmonton
International Airport, as well as is completing a fourth facility
in Lachute, Quebec through its
wholly owned subsidiary Aurora Larssen Projects Ltd.
In addition, the Company holds approximately 17.23% of the
issued shares in leading extraction technology company Radient
Technologies Inc., based in Edmonton, and is in the process of completing
an investment in Edmonton-based
Hempco Food and Fiber for an ownership stake of up to 50.1%.
Furthermore, Aurora is the cornerstone investor with a 22.9% stake
in Cann Group Limited, the first Australian company licensed to
conduct research on and cultivate medical cannabis. Aurora also
owns Pedanios, a leading wholesale importer, exporter, and
distributor of medical cannabis in the European Union, based in
Germany. The Company offers
further differentiation through its acquisition of BC Northern
Lights Ltd. and Urban Cultivator Inc., industry leaders,
respectively, in the production and sale of proprietary systems for
the safe, efficient and high-yield indoor cultivation of cannabis,
and in state-of-the-art indoor gardening appliances for the
cultivation of organic microgreens, vegetables and herbs in home
and professional kitchens. Aurora's common shares trade on the TSX
under the symbol "ACB".
On behalf of the Boards of Directors,
AURORA CANNABIS INC.
Terry Booth
CEO
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
Neither TSX nor its Regulation Services Provider (as that
term is defined in the policies of Toronto Stock Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
SOURCE Aurora Cannabis Inc.